"Bile Duct Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the BILE DUCTS.
| Descriptor ID |
D001650
|
| MeSH Number(s) |
C04.588.274.120.250 C06.130.120.120 C06.130.320.120 C06.301.120.250
|
| Concept/Terms |
Bile Duct Neoplasms- Bile Duct Neoplasms
- Bile Duct Neoplasm
- Neoplasm, Bile Duct
- Neoplasms, Bile Duct
Bile Duct Cancer- Bile Duct Cancer
- Bile Duct Cancers
- Cancer, Bile Duct
- Cancers, Bile Duct
- Cancer of the Bile Duct
- Cancer of Bile Duct
|
Below are MeSH descriptors whose meaning is more general than "Bile Duct Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bile Duct Neoplasms".
This graph shows the total number of publications written about "Bile Duct Neoplasms" by people in this website by year, and whether "Bile Duct Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 3 | 0 | 3 |
| 2005 | 4 | 0 | 4 |
| 2006 | 5 | 0 | 5 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 2 | 4 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 5 | 0 | 5 |
| 2023 | 4 | 1 | 5 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bile Duct Neoplasms" by people in Profiles.
-
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma. Am J Clin Oncol. 2024 Aug 01; 47(8):373-382.
-
Identification of RNF213 as a Potential Suppressor of Local Invasion in Intrahepatic Cholangiocarcinoma. Lab Invest. 2024 07; 104(7):102074.
-
Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors. J Vasc Interv Radiol. 2024 Jul; 35(7):989-997.e2.
-
Overexpression of HMGB1 in hepatocytes accelerates PTEN inactivation-induced liver cancer. Hepatol Commun. 2023 12 01; 7(12).
-
Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma. Eur Radiol. 2024 Apr; 34(4):2374-2383.
-
Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network. Ann Surg Oncol. 2023 Nov; 30(12):7362-7370.
-
Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience. J Vasc Interv Radiol. 2023 11; 34(11):1970-1976.e1.
-
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatol Commun. 2023 03 01; 7(3).
-
Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma. J Vasc Interv Radiol. 2023 04; 34(4):702-709.
-
Risk Factors for Abscess Development Following Percutaneous Microwave Ablation Therapy of Hepatic Tumors. Cardiovasc Intervent Radiol. 2023 Jun; 46(6):726-736.